Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial - Université de Reims Champagne-Ardenne Access content directly
Journal Articles Journal of Allergy and Clinical Immunology: In Practice Year : 2018

Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial

Catherine Goujon
  • Function : Author
Delphine Staumont-Sallé
  • Function : Author
Claire Bernier
  • Function : Author
Gérard Guillet
  • Function : Author
Morad Lahfa
  • Function : Author
Frédéric Cambazard
  • Function : Author
David Bottigioli
  • Function : Author
Sophie Grande
  • Function : Author
Karima Dahel
  • Function : Author
Frédéric Bérard
  • Function : Author
Muriel Rabilloud
Catherine Mercier
  • Function : Author
Jean-François Nicolas
  • Function : Author
Not file

Dates and versions

hal-03604974 , version 1 (10-03-2022)

Identifiers

Cite

Catherine Goujon, Manuelle Viguier, Delphine Staumont-Sallé, Claire Bernier, Gérard Guillet, et al.. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial. Journal of Allergy and Clinical Immunology: In Practice, 2018, 6 (2), pp.562-569.e3. ⟨10.1016/j.jaip.2017.07.007⟩. ⟨hal-03604974⟩

Collections

URCA IRMAIC
7 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More